2OStrategic inhibition of CEP55 in aggressive breast cancer leads to mitotic catastrophe

ConclusionsCollectively, we propose a novel treatment strategy of MEK1/2 -PLK1 dual combination for selectively targeting CEP55 over-expressing BC in the clinics.Legal entity responsible for the studyThe author.FundingNHMRC.DisclosureThe author has declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research